MAIA Biotechnology, Inc. (MAIA)

USD 1.94

(-11.82%)

Gross Profit Summary of MAIA Biotechnology, Inc.

  • MAIA Biotechnology, Inc.'s latest annual gross profit in 2023 was - USD , down 0.0% from previous year.
  • MAIA Biotechnology, Inc.'s latest quarterly gross profit in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • MAIA Biotechnology, Inc. reported a annual gross profit of - USD in annual gross profit 2022, down 0.0% from previous year.
  • MAIA Biotechnology, Inc. reported a annual gross profit of - USD in annual gross profit 2021, down 0.0% from previous year.
  • MAIA Biotechnology, Inc. reported a quarterly gross profit of - USD for 2024 Q1, down 0.0% from previous quarter.
  • MAIA Biotechnology, Inc. reported a quarterly gross profit of - USD for 2023 Q1, down 0.0% from previous quarter.

Annual Gross Profit Chart of MAIA Biotechnology, Inc. (2023 - 2019)

Historical Annual Gross Profit of MAIA Biotechnology, Inc. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%

Peer Gross Profit Comparison of MAIA Biotechnology, Inc.

Name Gross Profit Gross Profit Difference
AIM ImmunoTech Inc. 160 Thousand USD 100.0%
Ampio Pharmaceuticals, Inc. -250 Thousand USD 100.0%
Armata Pharmaceuticals, Inc. -29.24 Million USD 100.0%
Actinium Pharmaceuticals, Inc. -709 Thousand USD 100.0%
Azitra, Inc. 260.45 Thousand USD 100.0%
Can-Fite BioPharma Ltd. 743 Thousand USD 100.0%
Chromocell Therapeutics Corporation -2.57 Million USD 100.0%
Calidi Biotherapeutics, Inc. -1.25 Million USD 100.0%
CEL-SCI Corporation -3.95 Million USD 100.0%
iBio, Inc. -1.02 Million USD 100.0%
Lineage Cell Therapeutics, Inc. 8.27 Million USD 100.0%
Matinas BioPharma Holdings, Inc. -13.39 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. -119.29 Thousand USD 100.0%
NovaBay Pharmaceuticals, Inc. 7.89 Million USD 100.0%
NanoViricides, Inc. -759.01 Thousand USD 100.0%
Oragenics, Inc. -15.45 Million USD 100.0%
BiomX Inc. -1.22 Million USD 100.0%
BiomX Inc. -1.22 Million USD 100.0%
Protalix BioTherapeutics, Inc. 42.51 Million USD 100.0%
Palatin Technologies, Inc. 4.39 Million USD 100.0%
Scorpius Holdings, Inc. -2.21 Million USD 100.0%